Identity
- Trade Name
- InPen Smart Insulin System FDA UDI
- Generic Name
- Empty self-injector, mechanical FDA UDI
- Device Name
- The InPen is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments. The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data. For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use. For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use. FDA UDI
- Model / Reference
- Novo - Grey FDA UDI
- Description
- The InPen is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments. The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data. For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use. For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use. FDA UDI
Identifiers
- Catalog Number
- InPen-100NN-GY / MMT-105NNGY FDA UDI
- Primary DI / UDI-DI
- 10862088000351 FDA UDI
- 510(k) Number
- K201337 FDA UDI
- FDA Product Code
- FMF FDA UDINDC FDA UDI
- GMDN Term
- Empty self-injector, mechanical FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 880.5860 FDA UDI868.1890 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Empty self-injector, mechanical
InPen Smart Insulin System by Companion Medical, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Empty self-injector, mechanical.
- HumatroPen® 6 mg — ELI LILLY AND COMPANY · Class II
- Genotropin Pen® 5 — Pharmacia & Upjohn Co. · Class II
- HumatroPen® 24 mg — ELI LILLY AND COMPANY · Class II
- Omnitrope® Pen 5 — Sandoz Inc. · Class II
- InPen Smart Insulin Delivery System — MEDTRONIC MINIMED, INC. · Class II
- NovoPen Echo® — NOVO NORDISK INC. · Class II
- Omnitrope® Pen 10 — Sandoz Inc. · Class II
- InPen — MEDTRONIC MINIMED, INC. · Class II
Cleared under the same submission
K201337 also covers:
- InPen Smart Insulin Delivery System — COMPANION MEDICAL, INC.
- InPen Smart Insulin Delivery System — COMPANION MEDICAL, INC.
- inpen™ — COMPANION MEDICAL, INC.
- inpen™ — COMPANION MEDICAL, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
- inpen™ — MEDTRONIC MINIMED, INC.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Companion Medical, Inc.
Sources (1)
- FDA UDI bdea1908-12e8-4835-91aa-8274f4930319 36 fields · synced May 30, 2026